LabCorp launches EXACT's genomic colorectal cancer test
This article was originally published in Clinica
Laboratory Corporation of America (LabCorp) has made available through its nationwide network a DNA-based colorectal cancer test, PreGen-26. The test, which is based on EXACT Sciences' proprietary genomics-based technology, is intended to detect the presence of the actual disease, rather than being a predictive test for the condition.
You may also be interested in...
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.